Biopharmaceutical Company Silo Pharma Launches Cryptocurrency Fund Management Strategy
ChainCatcher reports that biopharmaceutical company Silo Pharma (NASDAQ: SILO) has announced the launch of a cryptocurrency fund management strategy and appointed crypto infrastructure expert Corwin Yu as the first member of its Cryptocurrency Advisory Board. The strategy will focus on major digital assets such as Bitcoin, Ethereum, and SOL.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Mt. Gox transfers 10,423 BTC to a new wallet, worth approximately $936 million
Panora adopts Chainlink's cross-chain interoperability standard on Aptos
Matrixport: ETH Faces Increased Short-term Risk as Bitmine Buying Subsides and New Capital Fails to Enter
LIBRA team withdrew USDC and purchased over 450,000 SOL, with an average entry price of $135
Trending news
MoreCrypto prices
More
